PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 224 filers reported holding PDL BIOPHARMA INC in Q2 2014. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $243,000 | +39.7% | 48,219 | +77.8% | 0.05% | +62.5% |
| Q2 2015 | $174,000 | -8.9% | 27,123 | -0.1% | 0.03% | -11.1% |
| Q1 2015 | $191,000 | -79.2% | 27,141 | -77.2% | 0.04% | -79.8% |
| Q4 2014 | $920,000 | -29.2% | 119,271 | -23.8% | 0.18% | +19.5% |
| Q1 2014 | $1,300,000 | -2.6% | 156,556 | -1.1% | 0.15% | -7.5% |
| Q4 2013 | $1,335,000 | +5.7% | 158,256 | -0.2% | 0.16% | -0.6% |
| Q3 2013 | $1,263,000 | +3.2% | 158,556 | 0.0% | 0.16% | -3.6% |
| Q2 2013 | $1,224,000 | – | 158,556 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |